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Severai platelet membrane glycoprotein
polymorphisms have been identified äs
Potential risk factors for cardiovascular
disease. Recently a nucleotide -5T/C di-
morphism m the translation Initiation site
(Kozak sequence) ofthe platelet glycopro-
tein Iba (GPIba) gene was associated
with increased platelet surface levels of
the GPIb-IX-V receptor complex. The role
of this GPIba Kozak sequence polymor-
phism m the occurrence of arterial throm-
botic disease is unknown. We performed
genotype analysis ofthe Kozak sequence
polymorphism of GPIba in a population-
Introduction
based study of 18- to 44-year-old women
with nonfatal myocardial infarction (MI)
(n = 78), nonfatal stroke (n = 106), and
384 demographically similar female con-
trol subjects. Analysis of -5T/C geno-
types revealed that at least one copy of
the C allele was present m 14.1% of MI
cases, 23.6% of stroke cases, and 23.7%
of controls. The age-adjusted odds ratio
for MI in women carrying at least one
copy of the C allele was 0.53 (95% confi-
dence mterval [Cl] 0.27-1.05). The age-
adjusted odds ratio for stroke in women
carrying at least one copy of the C allele
was 0.99 (95% Cl 0.59-1.65). Analyses
stratified by stroke type (ischemic, hemor-
rhagic) yielded similar results. In conclu-
sion, young women carrying the C allele
of the Kozak sequence polymorphism of
GPIba are not at increased risk of MI or
stroke. Paradoxically, the C allele may
even be associated with a reduced risk of
MI in this population. This finding re-
quires further study. (Blood. 2001 ;97:
875-879)
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The glycoprotein (GP) Ib-IX-V complex is the major platelet
surface receptor for von Willebrand factor (vWF) GPIb-IX-V
plays a key role in the adhesion of platelets to injured vascular
subendothelium and mediates shear-mduced platelet activation ' 2
Two polymorphisms m the GPIba gene affect the structure ofthe
protein The first is a size polymorphism resultmg from a variable
number of tandem repeats (VNTR) of a 13-amino acid sequence
with designated alleles A, B, C, and D The second is a Thr/Met
dimorphism at position 145 located in the vWF bmdmg domain of
GPIbot, which defines the human platelet alloantigen System
HPA-2 The HPA-2 and VNTR polymorphisms are in strong
hnkage disequilibrmm3 5
A third polymorphism of the GPIba gene that has been
descnbed moie recently mvolves a —5T/C dimorphism m the
translation Initiation sequence (Kozak sequence) 6·7 From previous
studies of the translation Initiation site, the nucleotides preceding
the ÄUG Initiator codons are thought to be important in translation
efficiency in eukaryotic cells8 The original consensus Kozak
sequence contarns nucleotide C at position —5, and therefore the
switch to T at the — 5 position of GPIba may theoretically decrease
translation efficiency of the receptor Afshar-Khargan et al6 re-
ported an association between the C allele of the Kozak dimor-
phism and increased platelet GPIb-IX-V receptor levels both in
vitro and m vivo
Because GPIb-IX-V receptor density may mfluence platelet
adhesion to exposed vascular subendothelium after atherosclerotic
plaque rupture, and thus affect risk of thrombosis, we assessedthe
relationship between the C allele of the Kozak sequence dimor-
phism of GPIba and risk of nonfatal MI and stroke among young
women in a population-based case-control study To assess poten-
tial gene-environment interactions, we also performed analyses
stratified by other known cardiovascular risk factors Finally,
because of the possible association between the HPA-2 and VNTR
polymorphisms and risk of atherothrombotic disease,9-11 we also
considered the potential confounding effects of these other GPIba
polymorphisms in our analysis
Patients, materials, and methods
Subjects
Approval for these studies was obtamed from the Umversity of Washmg-
ton's institutional review board Informed consent was provided accordmg
to the Declaration of Helsinki We used data and specimens from a
population-based case control study among women ages 18 to 44 years
hvmg in 3 contiguous counties of western Washington state between July l,
1991, and February 28, 1995 12 M Potential MI and stroke cases were
mitially identified by chart review of discharge diagnoses from all 34
hospitals and Emergency Medical Service incident reports in the study
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region Ehgible MI cases were women who had a probable MI diagnosed
usmg cntena of the Cardiovascular Health Study (CHS) H Stroke cases
were defined äs women with new neurologic deficits lasting more than 24
hours or resultmg m death in less than 24 hours and were classified by the
study neurologist äs ischemic, hemorrhagic, venous, or "other" (mcluding
artenal dissections) based on bram miaging studies and lumbar puncture
results Two hundred eight eligible MI patients and 249 stroke patients were
identified, and 161 of MI patients and 198 of stroke patients were hving at
the time recruitment was mitiated One hundred twelve MI and 149 stroke
patients were recruited and interviewed Six hundred eighty-four age-
matched female control subjects without history of cardiovascular disease
(CVD) were identified from the same geographic area by random digit
telephone dialmg Five hundred twenty six control subjects were recruited
and interviewed for the study (Table l)
Data collection
Case patients and control subjects were interviewed m person regardmg
histones of cardiovascular nsk factors, mcluding hypertension, diabetes
mellitus, hypercholesterolemia, cigarette smoking, height and weight,
menstrual history, contraceptive practices, history of MI m first-degree
relatives, and demographic charactenstics All quesüons elicited Informa-
tion from the penod before the MI or stroke in each case patient or an
eqmvalent date for control subjects A venous blood sample was collected
from 79 MI cases, 106 stroke cases, and 391 control subjects mto
EDTA treated vacuum tubes Ahquots ofplasma and buffycoat were frozen
at — 70°C Samples were sent to Leiden, The Netherlands, where DNA was
extracted äs descnbed by Miller et al16 Analyzable DNA was available for
78 MI cases, 106 stroke cases, and 384 controls
Laboratory analysis
Platelet genotyping for the GPIba Kozak polymorphism was performed by
polymerase chain reaction (PCR) amphfication of genomic DNA, followed
by restriction enzyme digestion, according to the method of Kaski et al7
Each reaction contamed 100 ng DNA, 4 pmol of each primer, 200 μΜ
dNTP, 0 4 umts of Taq polymerase, 2 μΙ_ 10Χ reaction buffer, and 16 μι.
water m a total volume of 20 μΐ. For the amplification, the samples were
heated to 93°C for 5 minutes, followed by 35 cycles of denaturation at 95°C
for 30 seconds, annealing at 65°C for 30 seconds, and extension at 72°C for
l minute, endmg with a final extension Step of 72°C for 5 mmutes The
amplification products were digested m a mixture of 5 umts of the
restriction enzyme Haelll, l μι. 10 X buffer, 3 5 μι. water, and 5 μι PCR
product, which was mcubated for 2 hours at 37°C Samples were analyzed
by electrophoresis on a 2% agarose gel and stained with ethidium bromide
Thirty-eight samples were randomly selected for duphcate testmg usmg the
methods previously descnbed with consistent results In addition, 5 samples
of each genotype (T/T, T/C, and C/C) were selected for direct nucleotide
sequencmg with confirmation of accuracy on all 15 samples
Platelet genotyping for the HPA-2 (Thr/Met145)17 and VNTR4 polymor
phisms of GPIba were performed äs previously descnbed
Variable defimtions and data analysis
Current smokers were defraed äs subjects who reported smoking currently
and regularly (at least 5 cigarettes per week for at least 6 consecutive
months), and all others were classified äs nonsmokers Obesity was defined
äs a body mass index (BMI) 27 3 kg/m2 or greater Hyperhomocystememia
was defined äs a serum homocysteme level greater lhan 126 μΜ Α woman
Table 1 Recruitment of study cases and control subjects
Ehgible cases by chart review
Living at time recruitment mitiated
Recruited and interviewed
Blood samples collected



















was classified äs hypertensive, hypercholesterolemic, or diabetic if she
reported ever receiving the diagnosis by a physician Women were
classified äs premenopausal if they (1) reported still having menstrual
penods, (2) were currently pregnant or nursmg, or (3) had undergone
hysterectomy but had at least one remaming functionmg ovary Family
history of early onset MI was defined äs having at least one first degree
relative who had an acute MI before the age of 55
The association of the C allele of the GPIba Kozak sequence
polymorphism with MI and stroke was exammed by calculation of the
age adjusted odds ratio (OR) and 95% confidence mterval (CI) usmg
unconditional logisüc regression The extent to which the association of the
C allele with nsk of MI or stroke was modified by other cardiovascular nsk
factors (smoking, hypertension, diabetes mellitus, hypercholesterolemia,
obesity, and homocysteinemia) was assessed through analyses stratified by
these other nsk factors To lest for the presence of interaction between the
Kozak C allele and these other cardiovascular nsk factors, multiphcative
terrns were mtroduced mto the logisüc regression model, and the P value
was computed for the likehhood ratio test comparmg the model contaming
the mteracüon term with the model lacking the interaction term To control
for the potential confounding effects of the GPIba ΗΡΑ 2 and VNTR
polymorphisms on the nsk of MI and stroke due to hnkage disequilibnum
with the Kozak sequence C allele, we also performed separate logistic
regression models that included either (1) an indicator variable encodmg the
presence (one copy ormore) of the less common HPA-2b (Met145) allele or
(2) 3 indicator variables encodmg the presence (one copy or more) of the
VNTR B, VNTR-C, and VNTR D alleles All data were analyzed usmg the
SAS package (Cary, NC)
Results
The charactenstics of the MI patients, stroke patients, and control
subjects are summarized m Table 2 The 78 women with acute MI
had a median age of 39 7 years (ränge 23 to 44) and the 106 women
with stroke a median age of 36 6 years (ränge 18 to 44) Most of the
study patients and control subjects were white There was a higher
Proportion of Afncan Amencans among the hemorrhagic stroke
and MI cases than m the control group The frequency of
cardiovascular nsk factors such äs smoking, obesity, hypercholes-
terolemia, hypertension, diabetes mellitus, and hyperhomocysteme-
mia was higher m the MI patients than control subjects For both
ischemic and hemorrhagic subtypes, the frequency of smoking,
hypertension, and hyperhomocysteinemia was higher in the stroke
patients than control subjects In contrast, higher frequencies of
obesity and diabetes were conflned to the ischemic stroke cases
The distnbution of the GPJba-50/Ί genotypes among the study
subjects is shown in Table 3 Among the control subjects, the
GPIba-ΧΙΎ genotype distnbution was m Hardy-Weinberg equihb-
num MI patients were less likely to have at least one copy of the C
allele compared with the control subjects (14 1% vs 23 7%),
although the frequency of the — 5C/C genotype was similar in both
groups (l 3% vs l 6%) The age-adjusted odds ratio for women
carrying at least one copy of the C allele (0 53, 95% CI = 0 27-
1 05) was virtually identical to the unadjusted OR (0 53, 95%
CI = 027-1 04) When adjusted additionally for obesity, homocys-
teme level, and diagnosis of hypertension, diabetes mellitus, or
hypercholesterolemia, the OR was 0 46 (95% CI = 0 22-0 96)
With the analysis restncted to the white population, the OR for the
age-adjusted model was 0 58 (95% CI = 0 28-1 20)
When stratified according to the presence or absence of known
cardiovascular risk factors, the presence of the C allele was not
associated with increased nsk of MI even in women with known
cardiovascular risk factors (Table 4) In women with obesity, the
age-adjusted OR was 081 (95% CI 033-194), with diabetes,
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MI indicates myocardial infarction
•Defined äs BMI a 27 3 kg/m2
fEver received the diagnosis based on subject interview
tDefi ned äs plasma homocysteine a 12 6 mg/dL
hypercholesterolemm, or hypertension was 0 83 (95%CI 0 35-
1 99), and with hyperhomocystememia was 0 92 (95% CI 0 34-
2 48) By contrast, in certam subgroups of women without
traditional cardiovascular nsk factors, the risk of MI associated
with the C allele was particularly low The age-adjusted OR m
women without obesity was 0 20 (95% CI 0 05 0 87), without
diabetes, hypercholesterolemia, or hypertension was 0 22 (95% CI
005 096), and without hyperhomocysteinemia was 036 (0 12-
1 05) However, none of these interactions between traditional
cardiovascular risk factors and the Kozak — 5C allele were
statistically signiflcant (Table 4)
Exammation of the GPIba genotypes m cases and controls
revealed strong linkage disequihbnum between the Kozak —5C
allele and the GPIba HPA-2a/VNTR C haplotypes For example,
analysis of the 551 subjects (1002 haplotypes) who are genetically
informative for the HPA-2 and — 5C/T dunorphisms (le, homozy-
gous for one or both dimoiphisms) levealed that all 120 of the
haplotypes that contain the — 5C allele also contam the ΗΡΑ 2a
allele In contrast, all 83 HPA-2b haplotypes were associated with
the — 5T allele In the remainmg 899 haplotypes, the — 5T allele
was associated with HPA-2a Because the GPIba HPA-2 and
VNTR polymorphisms have been associated with risk of athero-
thrombotic disease m other population studies,9 " we reanalyzed
the risk of MI associated with the Kozak sequence polymorphism
in our subjects, while separately controlling for the effects of the
HPA-2 and VNTR polymorphisms The OR for MI associated with
the presence of the Kozak C allele was 0 53 (95% CI 0 27-1 04)
after adjustmg for HPA-2, and 0 50 (95% CI 0 25-0 99) after
adjustmg for VNTR Furthermore, there was no evidence of effect
modification of the risk of MI associated with the Kozak C allele
when the subjects were stratified according to presence or absence
of the HPA-2b allele (Table 4)
Stroke patients overall were äs likely äs control subjects to have
at least one copy of the C allele (23 6% vs 23 7%) The age-
adjusted OR associated with ischemic stroke for women who
possessed at least one copy of the C allele was 0 99 (95%
CI = 0 59-1 65) When analyzed according to stroke subtype, there
was no association between carrying at least one copy of the C
allele and nsk of hemorrhagic or ischemic events (Table 3)
Additional adjustment for the HPA-2 and VNTR polymorphisms
did not appreciably change the results (data not shown) The 3
stroke cases who possessed the C/C genotype all had thromboem-
bolic events (2 had ischemic strokes and one had a cerebral venous
thrombosis) The frequency of the C/C genotype in the ischemic
stroke cases (4 9%) was higher compared with controls (l 6%), but
the difference was not statistically significant The age-adjusted OR
associated with ischemic stroke for women who possessed 2 copies
of the C allele was 321, but the confldence mterval is wide
(0 62-16 54), reflecting the small numbers of subjects
Discussion
The nucleotide — 5C Kozak sequence vanant of GPIba was
recently associated with increased translational efflciency and
mcieased platelet surface density of the GPIb IX-V receptor on





































(0 59 1 65)
(0 44-1 82)
(051 1 99)
MI indicates myocardial infarction OR oddsratio CI confidence mterval
*OR and 95% CI calculated for presence of C allele (homozygous or heterozygous) compared with TT genotype and adjusted for age
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(0 21 1 88)
(0 21-1 46)
(0 05-0 87)
(0 33 1 94)
(0 05-0 96)
(0 35 1 99)

















MI indicates myocardial mfarction, OR oddsratio, Cl confidence mterval, BMI body mass index
*OR and 95% Cl calculated for presence of C allele (homozygous or heterozygous) compared with TT genotype and adjusted for age
platelets äs well äs transfected cells expressmg the complex6 These
findmgs support the possibility of the Kozak sequence C allele äs a
candidate genetic susceptibility marker for atherothrombotic dis-
ease However, the role of the GPIba Kozak sequence polymor-
phism in the pathophysiology of artenal thrombotic disease has not
been well charactenzed We have assessed the GPIba Kozak
polymorphism in young women, a study sample that we have
previously used to demonstrate the importance of other genetic
prothrombotic factors m atherothrombotic disease and their poten-
tial interaction with other cardiovascular nsk factors12 n We found
no increased nsk of MI or stroke in young women who carry one or
more copies of the C allele of the Kozak sequence of GPIba
MI and stroke are unusual events in young women, thus our
study population is unique and well suited for analyzing potential
prothrombotic nsk factors The incidence of cardiovascular risk
factors such äs smoking and obesity are quite high in our
population, allowing us to analyze potential mteractions between
these known risk factors and new genetic factors We have
previously shown that factor V Leiden and prothrombin 20210 G to
A each increase the risk of MI m young women and interact
synergistically with other cardiovascular risk factors such äs
smoking 12·'3 It is therefore important to note that we find no
association between the GPIba-5C allele and increased risk of MI
in the same study population even in subgroups of women with
other cardiovascular risk factors
Our negative findmgs with respect to the C allele of the GPIba
Kozak sequence and increased risk of atherothrombotic events in
young women are consistent with several recent reports involvmg
predommantly middle-aged to older men In a case-control study of
539 patients with nonfatal MI, Croft et al18 found no association
with carnership of the C allele either overall (OR l 03) or in
subgroups of patients younger than 55 years old or defined by other
cardiovascular risk factors In a smaller hospital-based case-control
study, Corral et al19 observed no association between Kozak
genotype and acute coronary or cerebrovascular disease Similarly,
a prelimmary report indicated no association with unstable an-
gina 20 In contrast to these findings, another prelimmary report
noted an increased frequency of the C vanant of the GPIba Kozak
sequence in men younger than 55 and women younger than 65
years of age with a family history of early onset MI, but only when
individuals with a history of diabetes mellitus, hypertension, and
hypercholesterolemia were excluded 2I
In addition to the absence of an association with increased risk
of atherothrombotic disease m young women, our data suggest that
the C allele may even be associated with reduced risk of MI in this
population However, because of the relatively small numbers of
subjects and multiple subgroup compansons, these findings should
be interpreted cautiously This trend toward an mverse association
between the Kozak C allele and the risk of MI in young women
clearly requires confirmation m larger studies
The mechamsm for the possible mverse relationship of the C
allele of the GPIba Kozak sequence is not readily apparent One
may speculate that the "high expression" C allele is associated not
only with higher levels of the receptor on the platelet surface,6 but
also with increased circulating levels of the soluble extracellular
portion of GPIba glycocalicin Alternatively, the C allele may have
functional consequences for GPIba on another cell type (eg,
endothelial cells) that may influence the development of athero-
thrombotic disease via a causal pathway distmct from increased
platelet adhesion Fmally, because we analyzed only nonfatal MI
cases, it is theoretically possible that the apparent mverse associa-
tion results from selection bias due to a strong effect of the Kozak C
allele on case fatality (discussed below)
As previously reported in the Spamsh population,5 our results
mdicate strong linkage disequilibrium between the GPIba Kozak C
allele and the GPIba HPA-2a/VNTR-C haplotype The less
common HPA-2b/VNTR-B haplotype, which appears to be hnked
to the Kozak T allele, has been associated with increased risk of MI
and acute cerebral ischemia in some case-control studies9 " but not
in others192224 Thus, it is possible that the apparent mverse
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association between the Kozak — 5C allele and risk of MI could
result from its association with the "low nsk" HPA-2a/VNTR-C
haplotype In our study population of young women, there was a
trend toward an increased risk of ischemic stroke associated with
HPA-2b,25 but no evidence of an association between HPA-2 and
risk of MI (manuscript submitted) Furthermore, adjustment for
HPA-2 and VNTR did not significantly alter the estimates of effect
for the GPIba Kozak C allele m our current analysis Although
Afshar-Kharghan et al6 descnbed a dose-dependent increase in
GPIb-V-IX receptor levels associated with the C allele among
healthy platelet donors, Corral et al19 were unable to confirm any
difference m receptor levels between T/T and T/C mdividuals in a
larger number of subjects Thus, another possible explanation for a
possible inverse association with MI is that the Kozak polymor-
phism may be linked to a nearby gene that is important in
atherosclerosis or thrombosis
Our study has several limitations, including a small number of
subjects and multiple subgroup comparisons, which can potentially
lead to spurious associations ansmg by Chance The small sample
size also lacks the statistical power to detect some associations,
including the effect of the C/C genotype Lastly, the cases from
whom blood specimens for DNA analysis were obtamed mcluded
only women who survived at least 3 months after their MI or
stroke This resulted in exclusion of approximately 20% of the
cases imtially identifiedby chart review Thus, our study design can
References
only assess the relationship between genotype and nonfatal events,
and an association may have been missed if the C allele is strongly
associated with a high case fatality rate immediately after the acute
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cable approach, because MI and stroke among women under the
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In conclusion, our results suggest that young women carrymg
the C allele of the Kozak sequence polymorphism of GPIba are not
at increased risk of MI or stroke Paradoxically, the C allele may
even be associated with a reduced risk of MI in this population
These findings require confirmation in studies that mvolve larger
numbers of subjects and fatal events, äs well äs further elucidation
of the phenotypic consequences of the GPIba Kozak sequence
variant
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